← Back to Analyst Consensus 
SXTP Buy
60 DEGREES PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 22, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 37% |
| May 20, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Apr 9, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 37% |
| Jan 27, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $24 | 44% |
| Nov 28, 2025 | Ascendiant Capital | maintain | Buy → Buy | $2.8 | 37% |
| Sep 3, 2025 | Ascendiant Capital | maintain | Buy → Buy | $3 | 37% |
| Jun 2, 2025 | Ascendiant Capital | maintain | Buy → Buy | $7 | 37% |
| Mar 28, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Feb 25, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Jan 10, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Dec 23, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Dec 11, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Nov 15, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Sep 13, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Aug 15, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Jun 6, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Apr 3, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Oct 20, 2023 | HC Wainwright & Co. | initiate | — → Neutral | $0 | 44% |
| Oct 2, 2023 | Ascendiant Capital | initiate | — → Buy | $2.4 | 37% |
Price Target Trend
Mar 31, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
0y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days